Suresh, SN and Jayaprakash Rao, M and Manjithaya, R (2021) XCT 790 is a pharmacological aggrephagy inducer in a yeast model of proteotoxicity. In: Cell Biology International .
PDF
cel_bio_int_2021.pdf - Published Version Restricted to Registered users only Download (1MB) | Request a copy |
|
Image (TIFF)
cbin11518-sup-0001-fig_s1.tif - Published Supplemental Material Restricted to Registered users only Download (1MB) | Request a copy |
|
Image (TIFF)
cbin11518-sup-0002-fig_s2.tif - Published Version Restricted to Registered users only Download (1MB) | Request a copy |
|
Image (TIFF)
cbin11518-sup-0003-fig_s3.tif - Published Supplemental Material Restricted to Registered users only Download (659kB) | Request a copy |
|
Microsoft Word
cbin11518-sup-0004-supmat.doc - Published Supplemental Material Restricted to Registered users only Download (42kB) | Request a copy |
Abstract
Aggrephagy is a selective autophagic degradation intracellular mechanism that clears toxic misfolded protein aggregates such as α-synuclein. Here, we identify and demonstrate that the small molecule, XCT 790 alleviates α-synuclein-mediated adverse effects in a yeast model of proteotoxicity. XCT 790 induced general autophagy and also enhanced starvation-induced autophagy. Mechanistically, we showed that XCT 790 clears toxic α-synuclein aggregates in an autophagy-dependent manner. Interestingly, XCT 790 did not demonstrate a synergistic effect on autophagy induction in the presence of another autophagy inducer such as 6-Bio. © 2021 International Federation for Cell Biology
Item Type: | Journal Article |
---|---|
Publication: | Cell Biology International |
Publisher: | Blackwell Publishing Ltd |
Additional Information: | The copyright of this article belongs to Blackwell Publishing Ltd |
Department/Centre: | Autonomous Societies / Centres > Centre for Brain Research |
Date Deposited: | 16 Feb 2021 05:17 |
Last Modified: | 16 Feb 2021 05:17 |
URI: | http://eprints.iisc.ac.in/id/eprint/67964 |
Actions (login required)
View Item |